Engineering the human gut commensal Bacteroides thetaiotaomicron with synthetic biology

Curr Opin Chem Biol. 2022 Oct:70:102178. doi: 10.1016/j.cbpa.2022.102178. Epub 2022 Jun 24.

Abstract

The role of the microbiome in health and disease is attracting the attention of researchers seeking to engineer microorganisms for diagnostic and therapeutic applications. Recent progress in synthetic biology may enable the dissection of host-microbiota interactions. Sophisticated genetic circuits that can sense, compute, memorize, and respond to signals have been developed for the stable commensal bacterium Bacteroides thetaiotaomicron, dominant in the human gut. In this review, we highlight recent advances in expanding the genetic toolkit for B. thetaiotaomicron and foresee several applications of this species for microbiome engineering. We provide our perspective on the challenges and future opportunities for the engineering of human gut-associated bacteria as living therapeutic agents.

Keywords: Bacteroides; Genetic circuits; Human gut commensal bacteria; Living medicines; Microbiota; Synthetic biology.

Publication types

  • Review
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, N.I.H., Extramural

MeSH terms

  • Bacteroides thetaiotaomicron* / genetics
  • Humans
  • Microbiota*
  • Symbiosis
  • Synthetic Biology